Učitavanje...
Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report
BACKGROUND: Rituximab is a novel chimeric monoclonal antibody that has established itself as a potent therapeutic option for autoimmune medical conditions, including systemic lupus erythematosus, owing to its mechanism of action targeting CD20 cells. Rituximab is also known to cause a spectrum of si...
Spremljeno u:
| Izdano u: | J Med Case Rep |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264985/ https://ncbi.nlm.nih.gov/pubmed/34233732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02950-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|